Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of single intravenous
doses of the kappa opioid agonist CR845 in relieving pain in patients following
laparoscopic-assisted hysterectomy surgery. The study protocol was divided into two parts
with subjects either dosed with study drug the day following surgery (Cohort 1), or
immediately after surgery (Cohort 2).